Clinical governance is the term used to describe a systematic approach to maintaining and improving the quality of patient care within a health system. It is about the ability to produce effective change so that high quality care is achieved. It requires clinicians and administrators to take joint responsibility for making sure this occurs.
When clinical governance is effective, it has the potential to:
The role of the Drug and Alcohol Chief Addiction Medicine Specialist is to provide:
Alcohol and Other Drugs has a number of clinical governance programs, services and initiatives that address quality and safety issues, risk management, continuous improvement, workforce development and work with key stakeholders at committee level.
The QIT Sub-Committee reports to the NSW Health Drug and Alcohol Program Council on matters relating to improvements in clinical practice and quality of care. It consists of senior clinicians from the LHDs with representation from non-government organisations, nursing and allied health professionals.
The Drug and Alcohol Clinical Program is working with Aboriginal Drug and Alcohol leaders in NSW through the establishment of the Aboriginal Drug and Alcohol Network (ADAN). The ADAN Leadership Group meets regularly to discuss the development and delivery of Aboriginal drug and alcohol services in NSW. The ADAN holds an annual symposium. This project is run in partnership with the Aboriginal Health and Medical Research Council (AHMRC).